The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood

Haematologica

Volumn 88, Issue 5, 2003, Pages 561-569

  Sun, Rui ^a,b   Wei, Haiming ^a   Zhang, Jianhua ^b   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Cord blood; Ex vivo; Hematopoiesis; NK cells

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL COUNT; CELL CULTURE; CELL KINETICS; CELL POPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INCUBATION TIME; NATURAL KILLER CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; CELLS, CULTURED; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; KINETICS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE DEPLETION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038100455     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Erslev AJ. Clinical erythrokinetics: a critical review. Blood Rev 1997;11:160-7.
2. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976;58:705-15.
3. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-9.
4. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcome among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
5. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89:4109-13.
6. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
7. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-81.
8. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28:1197-205.
9. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-53.
10. + cells: effects of FLT3-L and MIP-1a on in vitro expansion of hematopoietic progenitor cells. Haematologica 1999;84:67582.
11. De Felice L, Di Pucchio T, Mascolo MG, Agostini F, Breccia M, Guglielmi C, et al. Flt3 L induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. Br J Haematol 1999; 106: 133-41.
12. Lazzari L, Lucchi S, Rebulla P, Porretti L, Puglisi G, Lecchi L, et al. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, flt3-ligand, interleukin (IL)-6 and IL-11 in serum-free and stromafree culture system. Br J Haematol 2001;112:397-404.
13. Ogawa M. Differentiation of hematopoietic stem cells. Blood 1993;81:2844-53.
14. Conneally E, Cashman J, Petzer A, Eaves CJ. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid_scid mice. Proc Natl Acad Sci USA 1997;94:9836-41.
15. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997;186:619-24.
16. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-53.
17. + cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999;93:3736-49.
18. + mobilized peripheral blood stem cells. Blood 1998;91:111-7.
19. Xu MJ, Tsuji K, Ueda T, Mukouyama YS, Hara T, Yang FC, et al. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood 1998;92:2032-40.
20. + cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 1999;94:106-13.
21. low/neg human bone marrow cells. Blood 1999;94:529-38.
22. Selleri C, Maciejewski JP, Sato T, Young NS. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 1996;87:4149-57.
23. Sato T, Selleri C, Young NS, Maciejewski JP. Hematopoietic inhibition by interferon-γ is partially mediated through interferon regulatory factor-1. Blood 1995;86:3373-80.
24. Koike K, Ma F, Shiohara M, Kubo T, Takagi M, Amano Y, et al. Interferon-γ inhibits proliferation, but not commitment, of murine granulocyte-macrophage progenitors. J Cell Physiol 1992;153:528-33.
25. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995;165:538-46.
26. Takahashi M, Oshimi K, Mizoguchi H. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon γ and tumor necrosis factor α. Exp Hematol 1990;18:395-9.
27. + T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunction. J Interferon Cytokine Res 1999;19:351-60.
28. Gazitt Y, He YJ. Down regulation of stem cell colony formation by purified CD8 lymphocytes and CD8 conditioned medium: potential importance for bone marrow transplantation in leukemia. Leuk Lymphoma 1992;8:117-27.
29. + lymphocytes. Blood 1988;72:1616-21.
30. Tian ZG, Woody MA, Sun R, Welniak LA, Raziuddin A, Funakoshi S, et al. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells 1998;16:193-9.
31. Tian ZG, Longo DL, Funakoshi S, Asai O, Ferris DK, Widmer M, et al. In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts. Cancer Res 1995;55:5335-41.
32. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92: 10119-22.
33. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
34. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-76.
35. McNiece I, Shpall E. Ex vivo expansion of hematopoietic progenitor cells from cord blood: clinical experience. Recent Developments in Cord Blood Stem and Progenitor Cell Transplantation: Third International Indianapolis Conference/Workshop, April 30-May 1, 2001.
36. + NK-T cells in whole blood. Cytometry 2000;39:72-8.
37. Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999;162:451120.
38. - cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 1997;180:132-42.
39. Ross ME, Caligiuri MA. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997;89:910-8.
40. bright natural killer cells in the human early pregnancy decidua. Int Immunol 1993;5:559-63.
41. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195:335-41.
42. + NK cells promote hematopoietic growth in H-2d strain mice. J Immunol 1995;155:2911-7.
43. Prosper F, Verfaillie CM. Regulation of hematopoiesis through adhesion receptors. J Leukoc Biol 2001;69:307-16.
44. Guenechea G, Gan OI, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001;2:75-82.
45. van Hennik PB, de Koning AE, Ploemacher RE. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999;94: 3055-61.
46. +)enriched cells from umbilical cord blood in NOD/LtSzscid/scid mice. Blood 1997;90:85-96.